161 related articles for article (PubMed ID: 21069156)
21. [Alpha-synucleinopathies].
Ferrer I
Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
[TBL] [Abstract][Full Text] [Related]
22. Amyloidogenic metal-binding proteins: new investigative pathways.
Davies P; Fontaine SN; Moualla D; Wang X; Wright JA; Brown DR
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1299-303. PubMed ID: 19021544
[TBL] [Abstract][Full Text] [Related]
23. Interactions between metals and alpha-synuclein--function or artefact?
Brown DR
FEBS J; 2007 Aug; 274(15):3766-74. PubMed ID: 17617226
[TBL] [Abstract][Full Text] [Related]
24. Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases.
Kawahara M; Kato-Negishi M; Tanaka K
Metallomics; 2017 Jun; 9(6):619-633. PubMed ID: 28516990
[TBL] [Abstract][Full Text] [Related]
25. The cell cycle and human neurodegenerative disease.
Vincent I; Pae CI; Hallows JL
Prog Cell Cycle Res; 2003; 5():31-41. PubMed ID: 14593698
[TBL] [Abstract][Full Text] [Related]
26. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
Paleologou KE; Irvine GB; El-Agnaf OM
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
[TBL] [Abstract][Full Text] [Related]
27. Interface between tauopathies and synucleinopathies: a tale of two proteins.
Galpern WR; Lang AE
Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
[TBL] [Abstract][Full Text] [Related]
28. [Cellular bases of neurodegenerative processes].
Nieoullon A
Therapie; 1998; 53(1):21-9. PubMed ID: 9773096
[TBL] [Abstract][Full Text] [Related]
29. Reactive oxygen species: stuck in the middle of neurodegeneration.
Patten DA; Germain M; Kelly MA; Slack RS
J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
Angot E; Brundin P
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S143-7. PubMed ID: 20082977
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein and its role in metal binding: relevance to Parkinson's disease.
Wright JA; Brown DR
J Neurosci Res; 2008 Feb; 86(3):496-503. PubMed ID: 17705291
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
[TBL] [Abstract][Full Text] [Related]
33. Does the expression of versican isoforms contribute to the pathogenesis of neurodegenerative diseases?
Zhang ZW; Zhang JP; Zhou TT; Feng WH; Jiao BH
Arch Med Res; 2011 Apr; 42(3):258-60. PubMed ID: 21722824
[TBL] [Abstract][Full Text] [Related]
34. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
35. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
El-Agnaf OM; Irvine GB
J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
[TBL] [Abstract][Full Text] [Related]
36. Proteopathy: the next therapeutic frontier?
Walker LC; LeVine H
Curr Opin Investig Drugs; 2002 May; 3(5):782-7. PubMed ID: 12090553
[TBL] [Abstract][Full Text] [Related]
37. Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates.
Hashimoto M; Ho G; Takamatsu Y; Shimizu Y; Sugama S; Takenouchi T; Waragai M; Masliah E
J Parkinsons Dis; 2018; 8(3):405-408. PubMed ID: 30010144
[TBL] [Abstract][Full Text] [Related]
38. Cell-to-cell transmission of non-prion protein aggregates.
Lee SJ; Desplats P; Sigurdson C; Tsigelny I; Masliah E
Nat Rev Neurol; 2010 Dec; 6(12):702-6. PubMed ID: 21045796
[TBL] [Abstract][Full Text] [Related]
39. Metallomics Applied to the Study of Neurodegenerative and Mental Diseases.
Sussulini A; Hauser-Davis RA
Adv Exp Med Biol; 2018; 1055():21-37. PubMed ID: 29884960
[TBL] [Abstract][Full Text] [Related]
40. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.
Liddell JR
Neurodegener Dis Manag; 2015 Aug; 5(4):345-64. PubMed ID: 26295717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
